Proteome Analysis of Differential Protein Expression in Brain of Rats with Type 1 Diabetes Mellitus

Abstract

Aim of the study: Proteomic approach was applied to identify differential protein expressed in brain of rats with type 1 diabetes mellitus (T1DM) in order to search for potential biomarkers for pathological changes of brain with T1DM.

Methods: Proteins were extracted from brain tissues of T1DM rats and healthy control rats, separated by 2-DE and identified by MALDI-TOF-MS. The results were validated by Western blot analysis and immunohistochemistry (IHC).

Results: A total of 8 proteins from the 24 differentially expressed spots were identified by MALDI-TOF-MS. The proteins identified were vitamin D-dependent calcium-binding protein, creatine kinase B-type (B-CK), myosin light chain kinase (MLCK), HSP60 and HSP71, ATP synthase, cyclin-G, pantothenate kinase-1 (PANK1), respectively. 3 proteins were up-regulated and 5 proteins were down-regulated from the T1DM rats. Of the 8 proteins identified, MLCK was confirmed by Western blot and IHC.

Conclusion: This work demonstrates that a comprehensive strategy of proteomic identification should be a useful tool for understanding of diabetic encephalopathy mechanism. And the differential proteins such as MLCK may be give clues about the pathogenesis of diabetic encephalopathy.

Key words

proteome - type 1 diabetes mellitus - brain - streptozotocin

References

• 1 Bao Y, Jiang L, Shi YQ. et al . Increased expression of phosphorylated Smad2 and Smad3 in the hippocampus of streptozotocin-induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2010;  118 (1) 47-50 [PubMed: 19834880]
• 2 Brands AM, Kessels RP, de Haan EH. et al . Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood glucose levels.  Eur J Pharmacol. 2004;  490 (1–3) 159-168 [PubMed: 15094082]
• 3 Fazeli SA. Neuroprotection in diabetic encephalopathy.  Neurodegenerative Dis. 2009;  6 (5–6) 213-218 [PubMed: 20145418]
• 4 Fountoulakis M. Application of proteomics technologies in the investigation of the brain.  Mass Spectrum Rev. 2004;  23 (4) 231-258 [PubMed: 15133836]
• 5 Fountoulakis M, Kossida S. Proteomics-driven progress in neurodegeneration research.  Electrophoresis. 2006;  27 (8) 1556-1573 [PubMed: 16555340]
• 6 He RX, Gu CL, Shen F. et al . Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats.  Chin Med J. 2007;  120 (3) 187-191 [PubMed: 17355819]
• 7 Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.  Am J Physiol Heart Circ Physiol. 2006;  291 (6) 2660-2668 [PubMed: 16951046]
• 8 Jian X, Szaro BG, Schmidt JT. Myosin light chain kinase: expression in neurons and up-regulation during axon regeneration.  J Neurobiol. 1996;  31 (3) 567-578 [PubMed: 8910795]
• 9 Li ZG, Sima AA. C-peptide and central nervous system complications in diabetes.  Exp Diabesity Res. 2004;  5 (1) 9-90 [PubMed: 15198373]
• 10 Liang XC, Guo SS, Hagino N. Current status of clinical and experimental researches on cognitive impairment in diabetes.  Chin J Integr Med. 2006;  12 (1) 68-74 [PubMed: 16571291]
• 11 Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive ageing.  Neurobiol Aging. 2005;  26 (suppl 1) 26-30 [PubMed: 16236384]
• 12 Mochida S, Kobayashi H, Matsuda Y. et al . Myosin II is involved in transmitter release at synapses formed between rat sympathetic neurons in culture.  Neuron. 1994;  13 (5) 1331-1142 [PubMed: 7946350]
• 13 Pandey A, Mann M. Proteomics to study genes and genomes.  Nature. 2000;  405 (6788) 837-846 [PubMed: 10866210]
• 14 Pasquier F, Boulogne A, Leys D. et al . Diabetes mellitus and dementia.  Diabetes Metab. 2006;  32 (5Pt1) 403-414 [PubMed: 17110895]
• 15 Rabilloud T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains.  Proteomics. 2002;  2 (1) 3-10 [PubMed: 11788986]
• 16 Ryan TA. Inhibitors of myosin light chain kinase block synaptic vesicle pool mobiliztion during action potential firing.  J Neurosci. 1999;  19 (4) 1317-1323 [PubMed: 9952409]
• 17 Sasaki N, Fukatsu R, Tsuzuki K. et al . Advanced glycation end products in Alzheimer's disease and other neurodegenerative disease.  Am J Pathol. 1998;  153 (4) 149-1155 [PubMed: 9777946]
• 18 Stasyk T, Morandell S, Bakry R. et al . Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining.  Electrophoresis. 2005;  26 (14) 2850-2854 [PubMed: 15966015]
• 19 Shin DH, Chun YS, Lee KH. et al . Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.  PLoS One. 2009;  14 (4) e7451 [PubMed: 19826488]
• 20 Sun Y, Zang Z, Xu X. et al . Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.  Int J Mol Sci. 2010;  11 (4) 1423-1433 [PubMed: 20480028]
• 21 van den Berg E, Reijmer YD, de Bresser J. et al . A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.  Diabetologia. 2010;  53 (1) 58-65 [PubMed: 19882137]
• 22 Wang T, Fu FH, Han B. et al . Aspirin attenuates cerebral ischemic injury in diabetic rats.  Exp Clin Endocrinol Diabetes. 2009;  117 (4) 181-185 [PubMed: 9053022]
• 23 Wild S, Roglic G, Green A. et al . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.  Diabetes Care. 2004;  27 (5) 1047-1053 [PubMed: 15111519]
• 24 Xu L, Li B, Cheng M. et al . Oral administration of grape seed proanthocyanidin extracts down-regulate RAGE dependant nuclear factor-kappa BP65 expression in the hippocampus of streptozotocin induced Diabetic rats.  Exp Clin Endocrinol diabetes. 2008;  116 (4) 215-224 [PubMed: 18273752]
• 25 Yang W, Lu J, Weng J. et al . Prevalence of diabetes among men and women in China.  N Engl J Med. 2010;  362 (12) 1090-1101 [PubMed: 20335585]
• 26 Zhang XG, Yan H, Shen YL. et al . Decreased thrombospondin-I (TSP-I) expression in the hippocampus of streptozotocin-induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2008;  116 (6) 309-314 [PubMed: 18700275]

Correspondence